SNOA stock Statistics — Sonoma Pharmaceuticals, Inc. filings, insiders & smart money

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstandingAs of 2026-08-06 · filed common shares: 4.78M
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 3.81%
Short ratioDays to cover, as published by FINRA: 2.36
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 23.70%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 22.50%
Avg volume (10D)

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Gross marginTTM to Jun 26: 38.91%
Operating marginTTM to Jun 26: -6.41%
Net margin: —
EBITDA marginTTM to Jun 26: -5.80%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: -42.52%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: -13.85%

Cash & equivalentsas of Jun 26: $5.33M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $739.00K
Debt / equityas of Jun 26: 11.21%
Current ratioas of Jun 26: 2.99
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 1.56
Operating cash flowTTM to Jun 26: -$2.56M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: -$2.65M
TTM revenue / diluted shareDiluted, TTM to Jun 26: 9.81